Clinical trial · Observational
Capillary-Venous Paired Data Collection
NCT05926362CI-TRIAL-00119811CaVeP-DCsuspendedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Paused for interim analysis
Summary
Brief summary (as posted)
Capillary-venous paired data collection.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy Subjects | — | UNRESOLVED | — |
| Medical Devices | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Cancer Cohort
- description
- This cohort are participants who are currently undergoing Systemic Anti-Cancer Treatment
- label
- Healthy Cohort
- description
- This cohort are participants who do not have any underlying conditions, to be used as a control group.
Primary outcomes (3)
- measure
- Coefficient of Variance of the difference between the lab results and the Liberty results
- timeFrame
- 3 years
- description
- the coefficient of variance (CV) between the lab results and the liberty results would be compared. a lower CV value signifies a better performance of our device.
- measure
- Bias (including %bias and absolute bias) between the lab results and the Liberty results
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
CANCER COHORT: Subjects fulfilling all of the following inclusion criteria are eligible for the study: * Age ≥18 years old at the time of study entry * Currently receiving standard-of-care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and targeted therapy) for solid organ malignancy * Scheduled to be undergoing routine venous laboratory blood tests as part of the standard of care * Able to provide capillary whole blood donation from pricking three different fingers on one hand * Can provide written informed consent * In the Investigator's opinion, is able and willing to comply with all study requirements The presence of any one of the following exclusion criteria will lead to the exclusion of the subject: * History or current diagnosis of haematological malignancy (including bone and lymph) * Inadequate use and understanding of the English language, requiring a translator HEALTHY COHORT Subjects fulfilling all of the following inclusion criteria are eligible for the study: * Age ≥18 years old at the time of study entry * Can provide written informed consent * Have an NHS number (to enable ordering and tracking of laboratory FBC tests) * Registered with a GP * In the Investigator's opinion, is able and willing to comply with all study requirements The presence of any one of the following exclusion criteria will lead to the exclusion of the subject: * Inadequate use and understanding of the English language, requiring a translator * Been hospitalised within 90 days prior to their study visit * Donated whole blood or plasma to a blood bank within the 90 days prior to the study visit * History of vasovagal syncope following blood draw * History or current diagnosis of the following conditions: * Cancer * Cardiovascular disease * Chronic kidney disease or end-stage renal disease * Bleeding disorder (including but not limited to Immune Thrombocytopenia (ITP), hemophilia, von Willebrand disease (VWD)) * Blood clotting disorder (including but not limited to thrombophilia, antiphospholipid syndrome) * G6PD deficiency * Inflammatory bowel disease * Myelodysplastic syndrome * Ebola * Tuberculosis * HIV * Hepatitis B or C * Current diagnosis of Epstein-Barr Virus or Cytomegalovirus * Current diagnosis of diabetes mellitus, unless controlled by diet alone OR participant has been taking the same dose of the same medication for 4 weeks or more and are feeling fit and well. * Undergone organ transplantation * Anemia, unless the participant is feeling fit and well (no dizziness, fatigue, shortness of breath etc)
References
Publications (0)
Data not yet available
No reference posted for this study.